EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Immunotherapy for malignant tumors with focus on toll‐like receptors

Yoko Manome, Dai Suzuki, Rie Nishida, Atsushi Yamada, Yoichi Miyamoto, Takahiro Funatsu, Ryutaro Kamijo

Oral Science International · 2019

DOI: 10.1002/osi2.1011 ↗
AbstractBibliografische Angaben

Abstract

Abstract One in three Japanese people will develop cancer during their lifetime and cancer is the leading cause of death in Japan, with prognosis known to worsen with development of distant metastasis. Recently, immunotherapy treatment for cancer has become established and shown to be more effective with fewer side effects as compared to other therapeutic options. As a result, toll‐like receptors (TLRs), which recognize molecules derived from many types of pathogens and activate the intra‐vital immune system, have become new targets for cancer immunotherapy treatment. In the present review, we provide an outline of immunotherapy procedures with a focus on TLRs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →